Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 14 recruiting now early-phase tilt

Depressive Disorder, Major: early-phase trial registry

14 of 53 indexed Depressive Disorder, Major trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #265 of 28,707 conditions by registered trial count.

53 US clinical trials · 14 currently recruiting · #265 of 28,707 conditions by registered trial count

Depressive Disorder, Major: 53 US clinical trials tracked, 14 recruiting.

Depressive Disorder, Major is the subject of 53 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is Janssen Research & Development, running 11 of these trials.

Enrollment posture brief

Registry condition depressive-disorder-major

OPEN 14 | RECR 26% | LATE 13 | EARLY 22 | RANK #265 | SPON 11

Nearest open-share peer: Anatomic Stage IIA Breast Cancer AJCC v8 (26% recruiting · 34 trials)

Mental Health Issue73.6%Metastatic Solid Tumor69.8%Hidradenitis Suppurativa54.7%Depressive Disorder, Maj (th…26%Medication Adherence24.5%
Open-enrollment share among volume-matched conditions near Depressive Disorder, Major

Depressive Disorder, Major lists 14 open slots (26% of 53 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Depressive Disorder, Major on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Depressive Disorder, Major is recruiting below its size-band peers.

    14 of 53 indexed trials (26.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Depressive Disorder, Major research.

    Janssen Research & Development accounts for 11 of 53 trials (20.8%). 32 distinct sponsors appear on at least one study for this condition label.

  3. Typical Depressive Disorder, Major enrolment sits around 124 participants.

    Median target enrolment is 124 among the 53 trials that report a genuine target (sentinel values excluded). 23 of those (43.4%) plan for fewer than 100 participants.

  4. Depressive Disorder, Major research is mostly interventional.

    45 interventional and 8 observational studies make up this index (84.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 16Phase 216Phase 312Phase 41

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 16
Phase 3 12
Phase 4 1

Named interventions

Most-linked intervention names on Depressive Disorder, Major records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
13 trials
Placebo Other
5 trials
LY2216684 Drug
3 trials
Aticaprant Drug
2 trials
Esketamine Drug
2 trials
placebo Drug
2 trials
Duloxetine Drug
2 trials
Intranasal device Device
1 trials

US sites by state

Facility locations filed on Depressive Disorder, Major trials. A trial with sites in several states counts in each.

California 30 trials
Florida 24 trials
Georgia 16 trials
Connecticut 15 trials
Massachusetts 11 trials
Colorado 11 trials
Alabama 10 trials
Texas 9 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Depressive Disorder, Major page

53 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Depressive Disorder, Major condition card totals 53 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.